Vera Ortiz-Santamaría

2.1k total citations · 1 hit paper
30 papers, 522 citations indexed

About

Vera Ortiz-Santamaría is a scholar working on Rheumatology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Vera Ortiz-Santamaría has authored 30 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 10 papers in Pathology and Forensic Medicine and 9 papers in Surgery. Recurrent topics in Vera Ortiz-Santamaría's work include Systemic Sclerosis and Related Diseases (9 papers), Systemic Lupus Erythematosus Research (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Vera Ortiz-Santamaría is often cited by papers focused on Systemic Sclerosis and Related Diseases (9 papers), Systemic Lupus Erythematosus Research (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Vera Ortiz-Santamaría collaborates with scholars based in Spain, Italy and Norway. Vera Ortiz-Santamaría's co-authors include Mercedes Pérez-Conesa, Xavier Vidal, Josefina Cortés-Hernández, Antoni Castro, Luís Sáez-Comet, Josep Ordi‐Ros, Cristina Solé, Antoni Riera‐Mestre, Eva Tomero and Alejandro Olivé and has published in prestigious journals such as Annals of Internal Medicine, The American Journal of Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

Vera Ortiz-Santamaría

28 papers receiving 515 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome

2019 204 citations Josep Ordi‐Ros, Luís Sáez-Comet et al. Annals of Internal Medicine profile →

Peers

Countries citing papers authored by Vera Ortiz-Santamaría

Since Specialization

Citations

This map shows the geographic impact of Vera Ortiz-Santamaría's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Ortiz-Santamaría with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Ortiz-Santamaría more than expected).

Fields of papers citing papers by Vera Ortiz-Santamaría

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Ortiz-Santamaría. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Ortiz-Santamaría. The network helps show where Vera Ortiz-Santamaría may publish in the future.

Co-authorship network of co-authors of Vera Ortiz-Santamaría

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Ortiz-Santamaría. A scholar is included among the top collaborators of Vera Ortiz-Santamaría based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Ortiz-Santamaría. Vera Ortiz-Santamaría is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis 2023 ·Thorax ·Sabina A. Guler, (unknown), Odile Stalder, Yannick Allanore, (unknown), Joerg H W Distler, Armando Gabrielli, Anna‐Maria Hoffmann‐Vold, Marco Matucci‐Cerinic, Ulf Müller‐Ladner, Vera Ortiz-Santamaría, Simona Rednic, Valeria Riccieri, Vanessa Smith, Susanne Ullman, Ulrich A. Walker, Thomas Geiser, Oliver Distler, Britta Maurer, Florian Kollert	15
2	Decreasing prevalence of chronic back pain in Catalonia. Analysis of the Catalan Health Survey 2022 ·Public Health ·Xavier Surís, Vera Ortiz-Santamaría, (unknown), (unknown), M. Larrosa, A. Ricart	1
3	POS0873 PERSISTENT INFLAMMATION IN SYSTEMIC SCLEROSIS IS STRONGLY ASSOCIATED WITH SEVERE DISEASE AND MORTALITY: AN ANALYSIS FROM THE EUSTAR DATABASE 2022 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), (unknown), Yannick Allanore, (unknown), (unknown), Andrea Gabrielli, (unknown), (unknown), Ulf Müller‐Ladner, Vera Ortiz-Santamaría, Simona Rednic, Valeria Riccieri, (unknown), Susanne Ullman, Ulrich A. Walker, (unknown), Oliver Distler, Britta Maurer, Florian Kollert	3
4	A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis 2020 ·Lupus ·(unknown), Javier Narváez, Tarek Carlos Salman-Monte, Raúl Castellanos‐Moreira, Vera Ortiz-Santamaría, Vicenç Torrente-Segarra, I. Castellví, (unknown), Dèlia Reina, (unknown), Meritxell Sallés, (unknown), (unknown), Elena Riera, Peter H. Schur, José A. Gómez‐Puerta	11
5	Silicosis, sarcoidosis and systemic sclerosis in the same patient 2020 ·Medicina Clínica (English Edition) ·(unknown), (unknown), Vera Ortiz-Santamaría	1
6	Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome breakdown → 2019 ·Annals of Internal Medicine ·Josep Ordi‐Ros, Luís Sáez-Comet, Mercedes Pérez-Conesa, Xavier Vidal, Antoni Riera‐Mestre, Antoni Castro, (unknown), Vera Ortiz-Santamaría, (unknown), Cristina Solé, Josefina Cortés-Hernández	204
7	Silicosis, sarcoidosis y esclerosis sistémica en un mismo paciente 2018 ·Medicina Clínica ·(unknown), (unknown), Vera Ortiz-Santamaría	0
8	Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial 2017 ·Annals of the Rheumatic Diseases ·Josep Ordi‐Ros, Luís Sáez-Comet, Mercedes Pérez-Conesa, Xavier Vidal, Francesca Mitjavila, Antoni Castro, Jordi Pedragosa, Vera Ortiz-Santamaría, Montserrat Plana, Josefina Cortés-Hernández	56
9	AB0451 Rivaroxaban versus warfarin as secondary thromboprophylaxis in patients with antiphospholipid syndrome protocol: a randomized, multicentre, open-label, clinical trial 2017 ·Annals of the Rheumatic Diseases ·Josefina Cortés-Hernández, Luís Sáez-Comet, Mercedes Pérez-Conesa, (unknown), Antoni Castro, Sandra Parra, (unknown), Vera Ortiz-Santamaría, (unknown), Pilar Suñé, Josep Ordi‐Ros	1
10	How many patients with rheumatic diseases and TNF inhibitors treatment have latent tuberculosis? 2016 ·Reumatología Clínica ·(unknown), Andrés Ponce, Vera Ortiz-Santamaría, Juan José de Agustín, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Miquel Torres, Xavier Surís	2
11	Nailfold capillaroscopic findings in primary Sjögren’s syndrome with and without Raynaud’s phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies 2015 ·Rheumatology International ·(unknown), Hèctor Corominas, Vera Ortiz-Santamaría, I. Castellví, Mireia Moreno, Rosa Morlà, Teresa Clavaguera, Alba Erra, (unknown), (unknown), (unknown), (unknown), Maria José González, (unknown), (unknown), (unknown), À. Olivé, Vicenç Torrente-Segarra	14
12	Un simulador clásico de vasculitis sistémica 2015 ·Reumatología Clínica ·(unknown), Vera Ortiz-Santamaría, (unknown), (unknown), (unknown)	3
13	Soporte nutricional a pacientes con esclerosis sistémica 2014 ·Reumatología Clínica ·Vera Ortiz-Santamaría, (unknown), (unknown), Anna Barata, Jordi Cuquet, (unknown)	16
14	Recién nacidos de madre con enfermedad autoinmunitaria. Experiencia en un hospital comarcal 2013 ·Reumatología Clínica ·Judith Sánchez-Manubens, Vera Ortiz-Santamaría, (unknown), Jordi Cuquet, (unknown), Xavier Surís, (unknown)	3
15	Nutrition in Systemic Sclerosis 2012 ·Reumatología Clínica (English Edition) ·(unknown), (unknown), Vera Ortiz-Santamaría	16
16	Nutrición en la esclerosis sistémica 2011 ·Reumatología Clínica ·(unknown), (unknown), Vera Ortiz-Santamaría	9
17	Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry 2011 ·Lara D. Veeken ·(unknown), Eva Tomero, M.Á. Descalzo, Andrés Ponce, Vera Ortiz-Santamaría, Xavier Surís, Loreto Carmona, Juan J. Gómez‐Reino	41
18	Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists 2005 ·The American Journal of Medicine ·Antonio Fernández‐Nebro, Eva Tomero, Vera Ortiz-Santamaría, (unknown), Alejandro Olivé, M. de Haro, (unknown), (unknown), A Laffón, Rosario García‐Vicuña	72
19	Estado de la asistencia reumatológica en el sector sanitario público de Cataluña 2005 ·Reumatología Clínica ·Vera Ortiz-Santamaría, Alejandro Olivé	9
20	Angiomatosis bacilar o sarcoma de Kaposi 2004 ·Revista Clínica Española ·Vera Ortiz-Santamaría, (unknown), (unknown), Alejandro Olivé Marquès	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact